Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Manhattan Associates Inc (MANH) vs Nuwellis Inc (NUWE) Price & Performance

Manhattan Associates IncTrade
Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

Manhattan Associates Inc vs Nuwellis Inc — how do they compare? Manhattan Associates Inc trades at $191.64 (market cap $11.38B), while Nuwellis Inc trades at $1.4 (market cap $542.80K). The key difference: Manhattan Associates Inc is far larger — about 20965.4× Nuwellis Inc's market cap, and Manhattan Associates Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.

MANHNUWE
Market Cap
$11.38B$542.80K
Sector
TechnologyTechnology
52-Week High
$220.19$220.50
52-Week Low
$120.88$1.42
Enterprise Value
$11.25B-$1.27M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Manhattan Associates Inc

MANH trades at $189.98, down 2.92% on the day, but maintains a bullish technical outlook with strong moving average signals and a golden cross formation. The company reported Q2 2026 EPS of $1.39, beating estimates, with cloud revenue growth driving performance. However, high valuation ratios like a P/E of 55.93 and P/B of 72.26 suggest premium pricing. Recent news highlights an ongoing legal investigation into fiduciary duties by Rosen Law Firm, adding a layer of scrutiny.

The stock's upside is supported by analyst consensus with a $210.33 price target and 80% buy ratings, but risks include elevated valuations, potential legal overhangs, and projected net cash flow turning negative in 2026. Investors should weigh robust profitability metrics against these headwinds for balanced decision-making.

Nuwellis Inc

NUWE trades at $1.43, up 0.7% on the day, with a bearish technical signal from moving averages but bullish oscillators. The company reported a net loss of -$17.52M in 2025, with a negative net income margin of -217.22%, though recent news highlights product development and revenue growth initiatives, including a 14% preliminary year-over-year revenue increase in Q2 2026.

Outlook is cautious due to persistent losses and high cash burn, but growth in pediatric installations and strategic expansions offer potential. Risks include financial sustainability and competitive pressures, while analyst coverage is limited with a split buy/hold consensus.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Manhattan Associates Inc

Manhattan Associates, Inc. is a global leader in supply chain and omnichannel commerce software. The company provides a comprehensive suite of cloud-based and on-premise solutions for warehouse management (WMS), transportation management (TMS), and order management (OMS). MANH's technology helps retailers, wholesalers, and manufacturers manage inventory, optimize logistics, and unify the shopping experience across physical and digital channels.

Read more on MANH

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE